A Phase II Study of Letrozole in Patients With Advanced or Recurrent Endometrial Cancer.
Phase of Trial: Phase II
Latest Information Update: 28 Mar 2016
At a glance
- Drugs Letrozole (Primary)
- Indications Endometrial cancer
- Focus Therapeutic Use
- 31 Aug 2018 Biomarkers information updated
- 21 Sep 2013 Additional lead trial centre added as reported by ClinicalTrials.gov.
- 18 Jan 2011 Actual initiation date (Jan 2000) added as reported by ClinicalTrials.gov.